Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients

APMIS

Volumn 101, Issue 1-6, 1993, Pages 168-175

  OJENIYI, B ^a   PETERSEN, U STEEN ^a   HOIBY N ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Genome fingerprinting; phage typing; Pseudomonas aeruginosa; reproducibility; serotyping

Indexed keywords

ARTICLE; BACTERIOPHAGE TYPING; CYSTIC FIBROSIS; GENOME IMPRINTING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

BACTERIAL TYPING TECHNIQUES; BACTERIOPHAGE TYPING; COMPARATIVE STUDY; CYSTIC FIBROSIS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOME, BACTERIAL; HUMAN; INCIDENCE; METHODS; PHENOTYPE; POLYMORPHISM (GENETICS); POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REPRODUCIBILITY OF RESULTS; SEROTYPING; SPUTUM;

EID: 0027262598     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1993.tb00097.x     Document Type: Article

References (28)

1. Phage typing of staphylococci
2. Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis
3. Experience with typing of coagulase‐negative staphylococci and micrococci
4. Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients
5. Further studies in the pyocine typing of Pseudomonas pyocyanea
6. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains
7. Untersuchungen über die O‐antigene von Pseudomonas aeruginosa
8. Reproducibility and indices of discriminatory power of microbial typing methods
9. Estimated risk of cross‐infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients
10. Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre
11. Simplified method for producing pyocins from Pseudomonas aeruginosa
12. Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa
13. Production of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa
14. Restriction enzyme and southern hybridization analyses of Pseudomonas aeruginosa strains from patients with cystic fibrosis
15. Serotyping of Pseudomonas aeruginosa 1. Study on the production of anti O sera
16. Serotyping of Pseudomonas aeruginosa 2. Result of an O group classification
17. Characterization and use of a DNA probe as an epidemiological marker for Pseudomonas aeruginosa
18. Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aeruginosa
19. A comparison of the efficiency in serotyping of Pseudomonas aeruginosa from cystic fibrosis patients using monoclonal and polyclonal antibodies
20. Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients
21. Genome fingerprinting as a typing method used on polyag‐glutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients
22. Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences
23. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre
24. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa
25. Bacteriophages in sputum of patients with bronchopulmonary Pseudomonas infection
26. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients
27. Pseudomonas aeruginosa cross‐colonization and persistence in patients with cystic fibrosis